Evaluating posaconazole, its pharmacology, efficacy and safety for the prophylaxis and treatment of fungal infections-Reference-Cited by-同舟云学术

Evaluating posaconazole, its pharmacology, efficacy and safety for the prophylaxis and treatment of fungal infections

Published:2021-11-10 Issue:2 Volume:23 Page:175-199
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Panagopoulou Paraskevi¹,Roilides Emmanuel²³

Affiliation:

1. 4th Department of Pediatrics, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, and Papageorgiou General Hospital, Thessaloniki, Greece

2. Infectious Diseases Unit, 3rd Department of Pediatrics, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, and Hippokration General Hospital, Thessaloniki, Greece

3. Basic and Translational Research Unit, Special Unit for Biomedical Research and Education, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece

Funder

not funded

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2021.1996562

Reference183 articles.

1. Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision

2. New facets of antifungal therapy

3. Posaconazole: An extended-spectrum triazole antifungal agent